Clinical Trial Update: Tezepelumab Home Use Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for tezepelumab home-use study in asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-07-29